study of unani formalation in joint pain

â??Effect of Majoon-e-Ushba and Habb-e-Suranjan in Rheumatoid Arthritisâ??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011861

Enrollment

Registered

2018-02-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Rheumatoid Arthritis

Interventions

Intervention1: Majoon-e-Ushba and Habb-e-Suranjan: Majoon-e-Ushba 5gm BD for 45 days and Habb-e-Suranjan 4 pills (each weighing 500mg) will be given orally thrice daily.for 45 days Control Interventio

Eligibility

Inclusion criteria

Inclusion criteria: Patients clinically diagnosed according to ACR criteria. Patient of either gender. Patients in age groups of 20 - 60 years.

Exclusion criteria

Exclusion criteria: Patients below 20 years and above 60 years of age. Systemic and metabolic illness like HTN,DM, TB and Malignancy. Pregnant and lactating women. Multiple joints pain other than RA. 5Cases of extra articular manisfestation of RA.

Design outcomes

Primary

Measure	Time frame
ESR CRP Simplified Disease Activity Index (SDAI) Health Assessment Questionnaire (HAQ) Timepoint: Before and after treatment	—

Secondary

Measure	Time frame
Morning stiffness Pain in joints Swelling Difficulty in movements Timepoint: Before treatment, 15th day, 30th day and 45th day	—

Countries

India

Contacts

Public ContactDr Abdul Mobeen

National Institute of Unani Medicine

dr.mobeen@rediffmail.com8123143721

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026